Literature DB >> 31846610

Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: an umbrella review.

Mario Cruciani1,2, Massimo Franchini1,3, Carlo Mengoli1,4, Giuseppe Marano1, Ilaria Pati1, Francesca Masiello1, Samantha Profili1, Eva Veropalumbo1, Simonetta Pupella1, Stefania Vaglio1,5, Giancarlo M Liumbruno1.   

Abstract

BACKGROUND: Platelet-rich plasma (PRP) has been used in different non-transfusion indications due to its role in tissue regeneration and healing. The aim of this overview of systematic reviews (umbrella review) is to provide a summary of the existing research syntheses related to PRP use for sports-related muscle, tendon and ligament injuries.
MATERIALS AND METHODS: Literature searches were performed in MEDLINE, Embase, and Cochrane Library to identify systematic reviews focusing on PRP use for sports-related muscle, tendon and ligament injuries. The methodological quality of included studies was assessed using the checklist for systematic reviews and research syntheses developed by the Joanna Briggs Institute and the GRADE assessment.
RESULTS: Twenty-two studies met the inclusion criteria. Five studies evaluated PRP use for acute muscle injury, and 17 evaluated PRP use for tendon and ligament injury. Studies were heterogeneous in terms of the dose and number of PRP injections, and the control groups. Three of the 5 reviews evaluating acute muscle injury concluded that PRP had no effect on the outcomes considered. One review shows superior efficacy of rehabilitation exercise compared to PRP. One review shows that PRP may result in an earlier return to sport for acute grade I-II injury. Eight out of the 17 reviews evaluating PRP for tendon and ligament injuries show a statistically significant (p<0.05) difference in pain and/or function outcome measures favouring PRP compared to controls, although most of the observed differences were small. Adverse events data and quality of life outcomes were rarely analysed or reported in the included studies and were considered clinically insignificant. DISCUSSION: In most of the included reviews, the available evidence was judged to be of low/very low quality due to risk of bias, inconsistency and imprecision, thus making the level of certainty of these findings low and not adequate to support the general use of PRP in this setting.

Entities:  

Mesh:

Year:  2019        PMID: 31846610      PMCID: PMC6917536          DOI: 10.2450/2019.0274-19

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  68 in total

1.  Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach.

Authors:  Edoardo Aromataris; Ritin Fernandez; Christina M Godfrey; Cheryl Holly; Hanan Khalil; Patraporn Tungpunkom
Journal:  Int J Evid Based Healthc       Date:  2015-09

Review 2.  Does the Use of Platelet-Rich Plasma at the Time of Surgery Improve Clinical Outcomes in Arthroscopic Rotator Cuff Repair When Compared With Control Cohorts? A Systematic Review of Meta-analyses.

Authors:  Bryan M Saltzman; Akshay Jain; Kirk A Campbell; Randy Mascarenhas; Anthony A Romeo; Nikhil N Verma; Brian J Cole
Journal:  Arthroscopy       Date:  2015-12-23       Impact factor: 4.772

3.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

4.  Efficacy of platelet-rich plasma for non-transfusion use: Overview of systematic reviews.

Authors:  Daniela Vianna Pachito; Carolina de Oliveira Cruz Latorraca; Rachel Riera
Journal:  Int J Clin Pract       Date:  2019-10-14       Impact factor: 2.503

5.  The Italian Regulatory Guidelines for the implementation of Patient Blood Management.

Authors:  Stefania Vaglio; Sara Gentili; Giuseppe Marano; Simonetta Pupella; Daniela Rafanelli; Gianni Biancofiore; Paola Antonioli; Claudio Velati; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-05-03       Impact factor: 3.443

6.  Intravenous iron administration for post-operative anaemia management after colorectal cancer surgery in clinical practice: a single-centre, retrospective study.

Authors:  María Jesús Laso-Morales; Roser Vives; Susana Gómez-Ramírez; Anna Pallisera-Lloveras; Caridad Pontes
Journal:  Blood Transfus       Date:  2018-03-05       Impact factor: 3.443

7.  The post-operative management of anaemia: more efforts are needed.

Authors:  Manuel Muñoz; Massimo Franchini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-03-05       Impact factor: 3.443

Review 8.  Platelet-rich therapies for musculoskeletal soft tissue injuries.

Authors:  Vinícius Y Moraes; Mário Lenza; Marcel Jun Tamaoki; Flávio Faloppa; João Carlos Belloti
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

Review 9.  Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systematic review and meta-analysis of controlled studies.

Authors:  I Andia; P M Latorre; M C Gomez; N Burgos-Alonso; M Abate; N Maffulli
Journal:  Br Med Bull       Date:  2014-05-02       Impact factor: 4.291

10.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18
View more
  2 in total

Review 1.  Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Promotion of Tendon Repair - an Update of Literature.

Authors:  Pauline Po Yee Lui
Journal:  Stem Cell Rev Rep       Date:  2021-04       Impact factor: 5.739

2.  Study protocol for a double-blind, randomised placebo-controlled trial evaluating clinical effects of platelet-rich plasma injection for acute grade-2 hamstring tear among high performance athletes.

Authors:  Mohamad Shariff A Hamid; Kamarul Hashimy Hussein; Ahmad Munawwar Helmi Salim; Arshad Puji; Rosnah Mat Yatim; Chin Chee Yong; Thomas Wong Yong Sheng
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.